Ros Deegan, CEO of <a href="https://www.omass.com/" rel="noopener noreferrer" target="_blank">OMass Therapeutics</a>, reflects on starting her biotech career in a downturn — and why that might have been the best teacher.In <a href="https://www.lifescienceorg.com/call-to-lead" rel="noopener noreferrer" target="_blank">A Call To Lead</a>, she shares why optionality has become central to her leadership, how she navigates constantly shifting paths, and what it takes to stay resilient when everything can change overnight.

Ros Deegan, CEO of OMass Therapeutics, reflects on starting her biotech career in a downturn — and why that might have been the best teacher. In A Call To Lead, she shares why optionality has become central to her leadership, how she navigates constantly shifting paths, and what it takes to stay resilient when everything can change overnight.

Ros Deegan, CEO of&nbsp;<a href="https://www.omass.com/" rel="noopener noreferrer">OMass Therapeutics</a>, reflects on starting her biotech career in a downturn — and why that might have been the best teacher.In <a href="https://www.lifescienceorg.com/call-to-lead" rel="noopener noreferrer">A Call To Lead</a>, she shares why&nbsp;optionality&nbsp;has become central to her leadership, how she navigates&nbsp;constantly shifting paths, and what it takes to stay&nbsp;resilient&nbsp;when everything can change overnight.

Ros Deegan, OMass Therapeutics

A Call To Lead is a series shining a light on the leadership, vision, and impact of European life science CEOs who are proving that world-class ventures don’t need to be built in Boston to shape the future of healthcare. 

Each episode features a one-on-one conversation with a European life science CEO and member of the LifeScience ORG community. Our conversations are not about companies or pipelines; instead, guests reflect on their personal journeys, the pivotal choices that shaped their careers, and the future they are helping to build. These kinds of insights are rarely shared publicly. 

New episodes are released every Thursday.

Business

Entrepreneurship

Science

Technology

Life Sciences

A Call To Lead is a series shining a light on the leadership, vision, and impact of European life science CEOs who are proving that world-class ventures don’t need to be built in Boston to shape the future of healthcare. Each episode features a one-on-one conversation with a European life science CEO and member of the LifeScience ORG community. Our conversations are not about companies or pipelines; instead, guests reflect on their personal journeys, the pivotal choices that shaped their careers, and the future they are helping to build. These kinds of insights are rarely shared publicly. New episodes are released every Thursday.

Share Ros Deegan, OMass Therapeutics

Sign up to save your podcasts

Ros Deegan, OMass Therapeutics

Ros Deegan, OMass Therapeutics